Core 1 Oncogenomics and Bioinformatics Core (OGB)

核心 1 肿瘤基因组学和生物信息学核心 (OGB)

基本信息

项目摘要

Shared Resource Core (OGB) Summary Human malignant neoplastic diseases have been extensively characterized by functional genomics approaches during the past decade, allowing the identification of different cancer molecular subtypes and the development of prognostic and predictive biomarkers. However, no studies have been reported comprehensively screening for the mutational and transcriptomic profiles of AIDS-associated malignancies (AM). The three interrelated projects of the U54 will employ the Next Generation Sequencing (NGS) platform to perform mutational and transcriptomics studies of AM biopsies as well as in-vitro and in vivo tumor studies using different murine models and cancer cell lines. Detailed unraveling of the AM genome coupled with a deeper understanding of its transcriptome and their viral associated factors will be instrumental to understand the molecular mechanisms and pathways that govern the progression of these neoplastic lesions. We will create a bilateral Oncogenomics (located at UM, USA) and Bioinformatics (located at UNLP, Argentina) Core (OGB) that will provide investigators access to resources not currently available for the Argentina Labs and centers investigators. The bilateral OGB-Core facility will be in charge of the design, generation, pre-processing, statistical and data mining analysis of the functional genomics data generated by the NGS platform available at OGB Core. The genomic data and clinical data will be centralized at the core server providing unified functional genomics resources that will serve as hub for coordinating converging approaches. Furthermore, the OGB Core will provide training to all junior scientists, Argentina investigators from the network as well as new investigators attracted via Pilots program offered by the U54 Consortium.
共享资源核心(OGB)摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SION LLEWELYN WILLIAMS其他文献

SION LLEWELYN WILLIAMS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SION LLEWELYN WILLIAMS', 18)}}的其他基金

Onco-Genomics Shared Resources
肿瘤基因组学共享资源
  • 批准号:
    10190861
  • 财政年份:
    2019
  • 资助金额:
    $ 9.93万
  • 项目类别:
Onco-Genomics Shared Resources
肿瘤基因组学共享资源
  • 批准号:
    10443638
  • 财政年份:
    2019
  • 资助金额:
    $ 9.93万
  • 项目类别:
Onco-Genomics Shared Resources
肿瘤基因组学共享资源
  • 批准号:
    9789585
  • 财政年份:
    2019
  • 资助金额:
    $ 9.93万
  • 项目类别:
Onco-Genomics Shared Resources
肿瘤基因组学共享资源
  • 批准号:
    10670843
  • 财政年份:
    2019
  • 资助金额:
    $ 9.93万
  • 项目类别:
Core 1 Oncogenomics and Bioinformatics Core (OGB)
核心 1 肿瘤基因组学和生物信息学核心 (OGB)
  • 批准号:
    10488065
  • 财政年份:
    2017
  • 资助金额:
    $ 9.93万
  • 项目类别:
Core 1 Oncogenomics and Bioinformatics Core (OGB)
核心 1 肿瘤基因组学和生物信息学核心 (OGB)
  • 批准号:
    10246317
  • 财政年份:
    2017
  • 资助金额:
    $ 9.93万
  • 项目类别:
Onco-Genomics Shared Resources
肿瘤基因组学共享资源
  • 批准号:
    9975823
  • 财政年份:
  • 资助金额:
    $ 9.93万
  • 项目类别:
Core 1 Oncogenomics and Bioinformatics Core (OGB)
核心 1 肿瘤基因组学和生物信息学核心 (OGB)
  • 批准号:
    9404860
  • 财政年份:
  • 资助金额:
    $ 9.93万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 9.93万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 9.93万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 9.93万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 9.93万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 9.93万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 9.93万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 9.93万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 9.93万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 9.93万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 9.93万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了